Fig. 5
From: Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells
CD133+ HPCs promotes the EMT process in breast cancer cells. Breast cancer cells were culture alone or co-culture with CD133- HUCBCs or CD133+ HPCs in Transwell plates, the relative levels of E-cadherin, N-cadherin and Vimentin to the control β-actin expression in breast cancer cells were quantified by Western blot. Data are representative images or present as the mean ± SD of each group from three separate experiments. a Western blot analysis. b Quantitative analysis of each protein expression. *P < 0.05, compared with CD133- HUCBCs group